198 related articles for article (PubMed ID: 28789433)
41. Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis.
Yen CJ; Yang ST; Chen RY; Huang W; Chayama K; Lee MH; Yang SJ; Lai HS; Yen HY; Hsiao YW; Wang JM; Lin YJ; Hung LY
J Biomed Sci; 2019 Jun; 26(1):44. PubMed ID: 31170980
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression.
Zhang Y; Liu H; Yi R; Yan T; He Y; Zhao Y; Liu J
J Exp Clin Cancer Res; 2016 Jun; 35(1):87. PubMed ID: 27255760
[TBL] [Abstract][Full Text] [Related]
43. Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis.
Jin XL; Hong SK; Kim H; Lee SK; Yi NJ; Lee KW; Suh KS
Oncol Lett; 2019 Nov; 18(5):4984-4991. PubMed ID: 31612010
[TBL] [Abstract][Full Text] [Related]
44. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
45. HBx-related long non-coding RNA 01152 promotes cell proliferation and survival by IL-23 in hepatocellular carcinoma.
Chen T; Pei J; Wang J; Luo R; Liu L; Wang L; Jia H
Biomed Pharmacother; 2019 Jul; 115():108877. PubMed ID: 31054511
[TBL] [Abstract][Full Text] [Related]
46. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
[TBL] [Abstract][Full Text] [Related]
47. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
48. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.
Moyo B; Nicholson SA; Arbuthnot PB
Virus Res; 2016 Jan; 212():103-13. PubMed ID: 26239319
[TBL] [Abstract][Full Text] [Related]
49. NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression.
Wan T; Lei Z; Tu B; Wang T; Wang J; Huang F
Front Oncol; 2021; 11():625169. PubMed ID: 33767993
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic knockdown of Notch1 inhibits hepatitis B virus X protein‑induced hepatocarcinogenesis of L02/HBx cells.
Peng Y; Zhou D; Ye Y; Kai C; Jiang Z; Zhu Z; Wu X; Xiong J
Oncol Rep; 2019 Feb; 41(2):1151-1159. PubMed ID: 30431136
[TBL] [Abstract][Full Text] [Related]
51. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
52. Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence.
Jin J; Jung HY; Lee KH; Yi NJ; Suh KS; Jang JJ; Lee KB
J Pathol Transl Med; 2016 May; 50(3):181-9. PubMed ID: 27086597
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma.
Wu Y; Zhang J; Zhang H; Zhai Y
Oncol Lett; 2016 Sep; 12(3):1971-1974. PubMed ID: 27602122
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B virus x gene-downregulated growth-arrest specific 5 inhibits the cell viability and invasion of hepatocellular carcinoma cell lines by activating Y-box-binding protein 1/p21 signaling.
Yu X; Ye Z; Hou L; Zhang X; Liu Z; Wu R; Huang F; Wang G; Geng X; Zhao H
J Cell Commun Signal; 2022 Jun; 16(2):179-190. PubMed ID: 34535871
[TBL] [Abstract][Full Text] [Related]
55. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.
Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z
Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J
Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140
[TBL] [Abstract][Full Text] [Related]
57. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
[TBL] [Abstract][Full Text] [Related]
58. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
[TBL] [Abstract][Full Text] [Related]
60. USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.
Qian Y; Wang B; Ma A; Zhang L; Xu G; Ding Q; Jing T; Wu L; Liu Y; Yang Z; Liu Y
Sci Rep; 2016 Sep; 6():33039. PubMed ID: 27633997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]